Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023:440:111-145.
doi: 10.1007/82_2022_261.

Lassa Virus Countermeasures

Lilia I Melnik  1
Affiliations

Lassa Virus Countermeasures

Lilia I Melnik. Curr Top Microbiol Immunol. 2023.

Abstract

Lassa Fever (LF) is a viral hemorrhagic fever endemic in West Africa. LF begins with flu-like symptoms that are difficult to distinguish from other common endemic diseases such as malaria, dengue, and yellow fever making it hard to diagnose clinically. Availability of a rapid diagnostic test and other serological and molecular assays facilitates accurate diagnosis of LF. Lassa virus therapeutics are currently in different stages of preclinical development. Arevirumab, a cocktail of monoclonal antibodies, demonstrates a great safety and efficacy profile in non-human primates. Major efforts have been made in the development of a Lassa virus vaccine. Two vaccine candidates, MeV-NP and pLASV-GPC are undergoing evaluation in phase I clinical trials.

PubMed Disclaimer

References

    1. Abreu-Mota T, Hagen KR, Cooper K, Jahrling PB, Tan G, Wirblich C, Johnson RF, Schnell MJ (2018) Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever. Nat Commun 9(1):4223 - PubMed - PMC
    1. Akahata W, Yang ZY, Andersen H, Sun S, Holdaway HA, Kong WP, Lewis MG, Higgs S, Rossmann MG, Rao S, Nabel GJ (2010) A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat Med 16(3):334–338 - PubMed - PMC
    1. Amanat F, Duehr J, Huang C, Paessler S, Tan GS, Krammer F (2020) Monoclonal antibodies with neutralizing activity and Fc-effector functions against the machupo virus glycoprotein. J Virol 94(5)
    1. Ambrosio A, Saavedra M, Mariani M, Gamboa G, Maiza A (2011) Argentine hemorrhagic fever vaccines. Hum Vaccin 7(6):694–700 - PubMed
    1. Ambrosio AM, Enria DA, Maiztegui JI (1986) Junin virus isolation from lympho-mononuclear cells of patients with Argentine hemorrhagic fever. Intervirology 25(2):97–102 - PubMed

LinkOut - more resources